0000000000707359

AUTHOR

Shoji Kudoh

showing 1 related works from this author

Interstitial lung disease associated with drug therapy

2004

Drug-associated interstitial lung disease (ILD) is not uncommon, with diverse patterns ranging from benign infiltrates to the potentially fatal acute respiratory distress syndrome. As acute respiratory failure due to drug-associated ILD has an unpredictable onset and rapid time course, establishing a diagnosis is often difficult. An accurate diagnosis is based on clinical, radiological (including high-resolution computed tomography) and histological manifestations, although is often only possible by exclusion. Cancer chemotherapy is commonly associated with acute disease that, on pathology, is often diffuse alveolar damage. Furthermore, a combination of drugs with or without radiotherapy ca…

PaperCancer Researchmedicine.medical_specialtyPathologyAntimetabolites AntineoplasticLung Neoplasmsmedicine.medical_treatmentDiseaseNSCLCchemotherapybehavioral disciplines and activitiesPharmacotherapyGefitinibJapanRisk FactorsCarcinoma Non-Small-Cell LungEpidemiologyAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansIntensive care medicineDiffuse alveolar damageLung cancerAgedinterstitial lung diseaseAged 80 and overRespiratory Distress Syndromegefitinib (‘Iressa’)business.industryInterstitial lung diseaseGefitinibrespiratory systemMiddle Agedmedicine.diseaserespiratory tract diseasesRadiation therapyOncologyQuinazolinesOral PresentationbusinessLung Diseases Interstitialmedicine.drugBritish Journal of Cancer
researchProduct